Literature DB >> 30421278

Lessons from one year experience of pooled procurement of pharmaceuticals: exploration of indicators and assessing pharmacies` performance.

Peivand Bastani1, Mohammad Hadi Imanieh2, Hesam Dorosti3, Reza Abbasi4, Seyyed Alireza Dashti5, Khosro Keshavarz6.   

Abstract

BACKGROUND: Joint procurement of medicines is a way to improve access and justice in developing countries. The aim of this study is to determine local indicators for assessing the performance of joint procurement agencies and compare the indicators in those pharmacies which use centralized purchasing before and after this change.
METHODS: This was a mixed method study. In the first qualitative phase, 3 expert panels were held including 20 national experts who were selected through purposeful sampling. Data was analyzed applying a five-stage framework analysis using MAXQDA. In the second quantitative phase, financial, supply and procurement, physical and functional indicators of two hospitals affiliated with joint procurement were assessed and the satisfactions of patients from the pharmacy performance were compared applying a valid questionnaire. Data was analyzed using SPSS through independent test, Paired t-test and ANOVA.
RESULTS: Results show that after settlement of joint procurement, the cost of transportation has increased by 54%, a part of the cost of overhead has increased by 30%, the cost of manpower has increased by 88.9% and cost of insurance of warehouses has increased by 71.85% in 2016 compared to 2015. In addition, the total costs of holding were 89.8% of selling revenue. In other words, the profit was about 10% of revenue in total. Moreover the average score of pharmacies under the Holding has been higher than similar ones in all aspects of satisfaction from the patients` points of view.
CONCLUSION: The one-year experience of deploying centralized purchasing to supply medicine has led to increased income and patient satisfaction. However, increase in staffing costs, longevity, overhead and warehouse costs have been significant that need appropriate monitoring and interventions. Graphical abstract Graphical abstract of lessons from one year experience of pooled procurement of pharmaceuticals in south of Iran.

Entities:  

Keywords:  Centralized purchasing; Indicators; Joint procurement; Pharmaceutical holding; Pooled procurement

Mesh:

Substances:

Year:  2018        PMID: 30421278      PMCID: PMC7214570          DOI: 10.1007/s40199-018-0228-y

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   3.117


  16 in total

1.  Sampling in Qualitative Research: Rationale, Issues, and Methods.

Authors:  Mark R Luborsky; Robert L Rubinstein
Journal:  Res Aging       Date:  1995-03-01

2.  One-year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan.

Authors:  Ibrahim Al-Abbadi; Abdelraouf Qawwas; Mahmoud Jaafreh; Taher Abosamen; Maisa Saket
Journal:  Clin Ther       Date:  2009-06       Impact factor: 3.393

3.  Clinical outcomes from the use of Medication Report when elderly patients are discharged from hospital.

Authors:  Patrik Midlöv; Eva Deierborg; Lydia Holmdahl; Peter Höglund; Tommy Eriksson
Journal:  Pharm World Sci       Date:  2008-07-25

4.  Resource allocation and purchasing arrangements to improve accessibility of medicines: Evidence from Iran.

Authors:  Peivand Bastani; Gholamhossein Mehralian; Rasoul Dinarvand
Journal:  J Res Pharm Pract       Date:  2015 Jan-Mar

5.  Pharmaceutical strategic purchasing: a key to improve access to medicines.

Authors:  Gholamhossein Mehralian; Peivand Bastani
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

6.  Decentralization and hospital pharmacy services: the case of Iranian university affilliated hospitals.

Authors:  Reza Ashna Delkhosh; Ali Ardama; Jamshid Salamzadeh
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 7.  Strategic contracting practices to improve procurement of health commodities.

Authors:  Leslie Arney; Prashant Yadav; Roger Miller; Taylor Wilkerson
Journal:  Glob Health Sci Pract       Date:  2014-06-24

8.  Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors.

Authors:  Peivand Bastani; Rasoul Dinarvand; Mahnaz SamadBeik; Kimia Pourmohammadi
Journal:  J Res Pharm Pract       Date:  2016 Jan-Mar

9.  Scoping literature review on the basic health benefit package and its determinant criteria.

Authors:  Ramin Hayati; Peivand Bastani; Mohammad Javad Kabir; Zahra Kavosi; Ghasem Sobhani
Journal:  Global Health       Date:  2018-03-02       Impact factor: 4.185

10.  Qualitative analysis of national documents on health care services and pharmaceuticals` purchasing challenges: evidence from Iran.

Authors:  Peivand Bastani; Mahnaz Samadbeik; Rassoul Dinarvand; Sara Kashefian-Naeeini; Soudabeh Vatankhah
Journal:  BMC Health Serv Res       Date:  2018-06-05       Impact factor: 2.655

View more
  2 in total

1.  Has the Volume-Based Drug Purchasing Approach Achieved Equilibrium among Various Stakeholders? Evidence from China.

Authors:  Qian Xing; Wenxi Tang; Mingyang Li; Shuailong Li
Journal:  Int J Environ Res Public Health       Date:  2022-04-03       Impact factor: 3.390

2.  Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design.

Authors:  Yu-Fei Hua; Jin Lu; Bing Bai; Han-Qing Zhao
Journal:  Front Public Health       Date:  2022-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.